Home › Cirrhosis › North Carolina
Cirrhosis clinical trials in North Carolina
6 studies for Cirrhosis are looking for participants at sites in North Carolina.
Cities in North Carolina
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Duke University Medical Center, Durham
- Coastal Research Institute, LLC, Fayetteville
- Carolina Researche, Greenville
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06632444A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Lucas Research, Inc., Morehead City
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 30, 2026 · NCT07325526Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Duke Liver Center, Durham
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT05832229National Liver Cancer Screening Trial
- University of North Carolina, Chapel Hill
RecruitingPhase 4
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06084234Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
- Research Site, Morehead City
- Research Site, Raleigh
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07610837Siemens Biomarker Multi-modality
- Duke University Medical Center, Durham
Recruiting
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT07495332From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.